Publications by authors named "Y Kadono"

Bone metastasis in the periacetabular region usually causes severe pain and functional disability. Some surgical procedures, such as the Harrington surgery and percutaneous cementoplasty, have been reported as treatment options for periacetabular bone metastases with limited efficacy. The former is highly invasive, while the latter may not allow the injection of a sufficient amount of cement.

View Article and Find Full Text PDF
Article Synopsis
  • Organized chronic subdural hematoma (OCSDH) is a rare condition with no standard treatment protocols, but recent outcomes show promise with middle meningeal artery (MMA) embolization.
  • Two cases are presented: an 83-year-old male with recurrent CSDH treated with craniotomy and MMA embolization showed symptom improvement and hematoma resolution after 6 months.
  • A 76-year-old male with thrombocytopenia was treated with MMA embolization and burr hole perforation; his symptoms also improved, and the hematoma resolved in 3 months, suggesting MMA embolization is a potential effective treatment for OCSDH.
View Article and Find Full Text PDF

Endovascular treatment for isolated dural arteriovenous fistula (DAVF) in the middle cranial fossa (MCF) with pure cortical venous drainage poses challenges, including the absence of a safe access route for transvenous embolization (TVE) and the risk of ischemia to neuro feeding vessels and dangerous anastomosis at the sphenoid wing. Therefore, surgical treatment involving direct blockage of venous reflux via craniotomy is typically preferred. We describe the case of a 63-year-old woman presented with generalized seizures and was diagnosed with a Borden III left MCF-DAVF.

View Article and Find Full Text PDF

Background: Only a few reports have currently studied the efficacy of dutasteride in patients with small benign prostatic hyperplasia (BPH). We investigated the efficacy of dutasteride on reducing lower urinary tract symptoms among them.

Materials And Methods: A total of 81 patients with BPH who completed 52weeks of 0.

View Article and Find Full Text PDF